Noesis Capital Mangement’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.3M | Buy |
135,684
+3,771
| +3% | +$435K | 2.41% | 18 |
|
|
2025
Q4 | $13.9M | Buy |
131,913
+2,882
| +2% | +$271K | 2.01% | 20 |
|
|
2025
Q3 | $10.8M | Buy |
129,031
+2,696
| +2% | +$222K | 1.68% | 24 |
|
|
2025
Q2 | $10M | Buy |
126,335
+8,620
| +7% | +$685K | 1.74% | 24 |
|
|
2025
Q1 | $10.6M | Buy |
117,715
+2,875
| +3% | +$268K | 2.1% | 20 |
|
|
2024
Q4 | $11.4M | Buy |
114,840
+2,689
| +2% | +$277K | 2.18% | 18 |
|
|
2024
Q3 | $12.7M | Buy |
112,151
+11,031
| +11% | +$1.31M | 2.53% | 17 |
|
|
2024
Q2 | $12.5M | Sell |
101,120
-103
| -0.1% | -$13.3K | 2.78% | 13 |
|
|
2024
Q1 | $13.4M | Sell |
101,223
-1,379
| -1% | -$170K | 2.97% | 13 |
|
|
2023
Q4 | $11.2M | Sell |
102,602
-437
| -0.4% | -$45.4K | 2.64% | 15 |
|
|
2023
Q3 | $10.6M | Buy |
103,039
+1,389
| +1% | +$150K | 2.78% | 12 |
|
|
2023
Q2 | $11.7M | Buy |
101,650
+90
| +0.1% | +$10.2K | 2.89% | 14 |
|
|
2023
Q1 | $10.8M | Buy |
101,560
+97,984
| +2,740% | +$10.6M | 2.74% | 14 |
|
|
2022
Q4 | $397K | Sell |
3,576
-244
| -6% | -$24.9K | 0.11% | 67 |
|
|
2022
Q3 | $329K | Sell |
3,820
-244
| -6% | -$21.8K | 0.1% | 72 |
|
|
2022
Q2 | $371K | Sell |
4,064
-5,407
| -57% | -$479K | 0.11% | 70 |
|
|
2022
Q1 | $777K | Sell |
9,471
-5,356
| -36% | -$422K | 0.19% | 53 |
|
|
2021
Q4 | $1.14M | Sell |
14,827
-5,160
| -26% | -$411K | 0.23% | 48 |
|
|
2021
Q3 | $1.5M | Buy |
19,987
+1,650
| +9% | +$125K | 0.29% | 43 |
|
|
2021
Q2 | $1.43M | Sell |
18,337
-907
| -5% | -$67.5K | 0.29% | 44 |
|
|
2021
Q1 | $1.42M | Buy |
19,244
+826
| +4% | +$60.9K | 0.32% | 41 |
|
|
2020
Q4 | $1.44M | Buy |
18,418
+116
| +0.6% | +$8.87K | 0.36% | 41 |
|
|
2020
Q3 | $1.45M | Hold |
18,302
| – | – | 0.41% | 42 |
|
|
2020
Q2 | $1.35M | Sell |
18,302
-91
| -0.5% | -$6.85K | 0.43% | 39 |
|
|
2020
Q1 | $1.35M | Sell |
18,393
-629
| -3% | -$49.4K | 0.5% | 36 |
|
|
2019
Q4 | $1.65M | Sell |
19,022
-210
| -1% | -$17.2K | 0.46% | 37 |
|
|
2019
Q3 | $1.54M | Buy |
19,232
+202
| +1% | +$16.2K | 0.5% | 36 |
|
|
2019
Q2 | $1.52M | Buy |
19,030
+579
| +3% | +$44.3K | 0.52% | 34 |
|
|
2019
Q1 | $1.46M | Sell |
18,451
-838
| -4% | -$62.7K | 0.53% | 35 |
|
|
2018
Q4 | $1.41M | Hold |
19,289
| – | – | 0.57% | 34 |
|
|
2018
Q3 | $1.31M | Hold |
19,289
| – | – | 0.46% | 37 |
|
|
2018
Q2 | $1.12M | Buy |
19,289
+50
| +0.3% | +$2.82K | 0.41% | 40 |
|
|
2018
Q1 | $1M | Sell |
19,239
-111
| -0.6% | -$6K | 0.37% | 43 |
|
|
2017
Q4 | $1.04M | Buy |
19,350
+86
| +0.4% | +$4.77K | 0.37% | 46 |
|
|
2017
Q3 | $1.18M | Sell |
19,264
-208
| -1% | -$12.6K | 0.44% | 44 |
|
|
2017
Q2 | $1.19M | Sell |
19,472
-436
| -2% | -$26.5K | 0.46% | 44 |
|
|
2017
Q1 | $1.21M | Buy |
19,908
+1,616
| +9% | +$98K | 0.46% | 44 |
|
|
2016
Q4 | $1.03M | Buy |
18,292
+1
| +0% | +$59 | 0.43% | 44 |
|
|
2016
Q3 | $1.09M | Buy |
18,291
+342
| +2% | +$20K | 0.47% | 44 |
|
|
2016
Q2 | $987K | Buy |
17,949
+105
| +0.6% | +$5.59K | 0.44% | 44 |
|
|
2016
Q1 | $901K | Buy |
17,844
+136
| +0.8% | +$6.66K | 0.41% | 45 |
|
|
2015
Q4 | $892K | Sell |
17,708
-314
| -2% | -$15.8K | 0.42% | 43 |
|
|
2015
Q3 | $849K | Hold |
18,022
| – | – | 0.45% | 43 |
|
|
2015
Q2 | $979K | Sell |
18,022
-302
| -2% | -$16.9K | 0.42% | 45 |
|
|
2015
Q1 | $1M | Sell |
18,324
-598
| -3% | -$33.9K | 0.42% | 48 |
|
|
2014
Q4 | $1.02M | Sell |
18,922
-469
| -2% | -$26.1K | 0.43% | 48 |
|
|
2014
Q3 | $1.1M | Buy |
19,391
+6,780
| +54% | +$381K | 0.48% | 45 |
|
|
2014
Q2 | $696K | Buy |
12,611
+1,399
| +12% | +$76.3K | 0.31% | 71 |
|
|
2014
Q1 | $607K | Sell |
11,212
-366
| -3% | -$19K | 0.3% | 74 |
|
|
2013
Q4 | $553K | Sell |
11,578
-249
| -2% | -$11.4K | 0.27% | 77 |
|
|
2013
Q3 | $537K | Hold |
11,827
| – | – | 0.28% | 82 |
|
|
2013
Q2 | $524K | Buy |
+11,827
| New | +$528K | 0.28% | 83 |
|
Other funds holding MRK
VCM
VPM
Noesis Capital Mangement's MRK Position: Q1 2026 in Review
Noesis Capital Mangement increased its Merck (MRK) stake by 2.9% in Q1 2026, buying an estimated $435K and bringing the position to 135,684 shares worth $16.3M. The position accounts for 2.41% of the portfolio, ranked #18.
Noesis Capital Mangement first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Noesis Capital Mangement held 135,684 shares of Merck worth $16.3M as of Q1 2026.
- Noesis Capital Mangement bought 3,771 Merck shares in Q1 2026, an estimated $435K.
- Merck made up 2.41% of Noesis Capital Mangement's portfolio in Q1 2026, its #18 holding.
- Noesis Capital Mangement first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Noesis Capital Mangement's 13F filing for Q1 2026, filed 5 May 2026.